Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
453.70    -5.90 (-1.28%)
Bid:
454.70
Ask:
454.90
Spread: 0.20 (0.044%)
Market Cap: £5.65b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Disposal

6 Jun 2022 07:00

RNS Number : 6934N
Melrose Industries PLC
06 June 2022
 

3 June 2022

MELROSE INDUSTRIES PLC

 

SALE OF ERGOTRON

 

Sale of Ergotron

Melrose Industries PLC ("Melrose", the "Company" or the "Group") has entered into an agreement to sell its Ergotron business ("Ergotron"), to funds managed by The Sterling Group ("Sterling") for total consideration of approximately $650 million (c.£520 million), payable in cash on completion (the "Disposal"). Ergotron is a leading designer, manufacturer and distributor of ergonomic products for use in a variety of working, learning and healthcare environments, with gross assets (mostly goodwill) as at 31 December 2021 of £617 million and 2021 adjusted operating profit of £58 million (2021 EBITDA £62 million). 

Completion of the Disposal is expected to occur in the third quarter of 2022 ("Completion") and is conditional upon customary US antitrust approvals. On or before Completion, Melrose will announce how it intends to use the net proceeds from the Disposal. 

 

Successful execution of Melrose's strategy for Nortek

Having sold the Nortek Air Management and Nortek Control businesses last year, Ergotron is the last of the businesses remaining from the Nortek Inc acquisition in 2016. On Completion, Melrose will have more than doubled shareholders' initial investment, whilst transforming the Nortek businesses themselves.

Refocusing them away from unprofitable work, Melrose made the significant investment necessary to implement operational best practices, increase R&D, develop new products and build stronger customer relationships. These actions resulted in an almost doubling of adjusted operating margins and ensured each business remained highly cash generative, with over $1 billion generated during Melrose ownership.

This strong support and appropriate investment under Melrose ownership unlocked the potential of all the Nortek businesses and set them on the path for further success under new owners for the next stage of their development. 

 

Simon Peckham, Chief Executive of Melrose, today said:

"The sale of Ergotron is the final step in our Nortek ownership cycle, capping what has been a very successful acquisition for Melrose shareholders. We will have more than doubled shareholders' equity investment in Nortek and have transformed the businesses themselves. Our attention now remains firmly on achieving the same result for the current Group." 

 

Enquiries:

Investor Relations:

+44 (0) 7974 974690

ir@melroseplc.net

 

Montfort Communications - Financial PR:

+44 (0) 20 3514 0897

Nick Miles miles@montfort.london

+44 (0) 7739 701634

Charlotte McMullen mcmullen@montfort.london

+44 (0) 7921 881 800

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISBCGDLXXGDGDU
Date   Source Headline
26th Sep 20227:00 amRNSHolding(s) in Company
13th Sep 20228:30 amRNSDividend record date correction
8th Sep 20227:00 amRNSHalf-year Report
31st Aug 20223:46 pmRNSTotal Voting Rights
2nd Aug 20227:30 amRNSTransactions in Own Shares
1st Aug 20227:30 amRNSTransactions in Own Shares
1st Aug 20227:00 amRNSTotal Voting Rights
29th Jul 20227:30 amRNSTransactions in Own Shares
28th Jul 20227:30 amRNSTransactions in Own Shares
27th Jul 20227:30 amRNSTransactions in Own Shares
26th Jul 20227:30 amRNSTransactions in Own Shares
25th Jul 20227:30 amRNSTransactions in Own Shares
22nd Jul 20227:30 amRNSTransaction in Own Shares
21st Jul 202210:30 amRNSHolding(s) in Company
21st Jul 20227:30 amRNSTransaction in Own Shares
20th Jul 20227:30 amRNSTransaction in Own Shares
19th Jul 20227:30 amRNSTransaction in Own Shares
18th Jul 20227:30 amRNSTransaction in Own Shares
15th Jul 20227:30 amRNSTransaction in Own Shares
14th Jul 20227:30 amRNSTransaction in Own Shares
13th Jul 20227:30 amRNSTransaction in Own Shares
12th Jul 20227:30 amRNSTransaction in Own Shares
11th Jul 20227:30 amRNSTransactions in Own Shares
8th Jul 20227:30 amRNSTransactions in Own Shares
7th Jul 20227:00 amRNSTransactions in Own Shares and Disposal Completion
6th Jul 20224:15 pmRNSTR-1: standard notification of major holdings
6th Jul 20227:30 amRNSTransactions in Own Shares
5th Jul 20227:30 amRNSTransactions in Own Shares
4th Jul 20227:30 amRNSTransactions in Own Shares
1st Jul 20227:30 amRNSTransactions in Own Shares
30th Jun 202210:09 amRNSTotal Voting Rights
30th Jun 20227:30 amRNSTransactions in Own Shares
29th Jun 20227:30 amRNSTransactions in Own Shares
28th Jun 20227:30 amRNSTransaction in Own Shares
27th Jun 20227:30 amRNSTransaction in Own Shares
24th Jun 20227:30 amRNSTransaction in Own Shares
23rd Jun 20227:30 amRNSTransaction in Own Shares
22nd Jun 20227:30 amRNSTransaction in Own Shares
21st Jun 20227:30 amRNSTransaction in Own Shares
20th Jun 20227:30 amRNSTransaction in Own Shares
17th Jun 20227:30 amRNSTransaction in Own Shares
16th Jun 20227:30 amRNSTransaction in Own Shares
15th Jun 20227:30 amRNSTransaction in Own Shares
14th Jun 20227:30 amRNSTransaction in Own Shares
13th Jun 20227:30 amRNSTransaction in Own Shares
10th Jun 20227:30 amRNSTransaction in Own Shares
9th Jun 20225:30 pmRNSSustainability Report
8th Jun 20227:00 amRNSShare Buyback Programme
7th Jun 20224:45 pmRNSCapital Markets Day
6th Jun 20227:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.